MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.860 +0.150 (+3.18%)
Streaming Delayed Price Updated: 11:38 AM EST, Dec 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
21 22 Next >
News headline image
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 150 points on Thursday. Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose during Thursday’s session following... 
Via Benzinga
Topics Stocks
News headline image
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer 
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought in 2024 ↗
The widely followed aggressive growth investor is adding to some of her holdings as she kicks off the new year. 
Via The Motley Fool
News headline image
Peering Into Recursion Pharmaceuticals's Recent Short Interest ↗
 
Via Benzinga
News headline image
2 Cathie Wood Stocks That Might Be Smart Buys Right Now ↗
These two biotech stocks hold enormous potential. 
Via The Motley Fool
News headline image
Looking Into Recursion Pharmaceuticals's Recent Short Interest ↗
 
Via Benzinga
News headline image
This Stock Could Soar by 120%, According to Wall Street ↗
Don't rush to buy shares just yet. 
Via The Motley Fool
News headline image
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Cathie Wood's Ark Invest Purchases Nearly $17M Worth Of Roku Shares, Sells Coinbase, Robinhood Stock ↗
 
Via Benzinga
News headline image
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth ↗
Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today. 
Via InvestorPlace
News headline image
AI-Focused Drug Discovery Stocks Index Up 26% In December ↗
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions. 
Via Talk Markets
News headline image
Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher ↗
On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before. 
Via Investor's Business Daily
News headline image
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry
Screening libraries will leverage Recursion's MatchMaker tool to identify compounds across Enamine REAL Space predicted to bind to high-value targets. 
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
3 Genomics Stocks to Unlock the Future of Medicine ↗
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use. 
Via InvestorPlace
News headline image
These Are the 3 Hottest Biopharma Trends of 2024. Should You Invest? ↗
2024 is going to be a sizzler in the biopharma sector. 
Via The Motley Fool
News headline image
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week ↗
A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method. 
Via Talk Markets
Topics Artificial Intelligence
News headline image
AI Meets Biotech: 3 Top Stocks Transforming Medical Science ↗
The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock ↗
Wood is moving away from fintech and Internet names like COIN stock. She's now favoring genomics and artificial intelligence companies. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
These 9 Micro/Small Cap AI Stocks Continue In Bubble Mode ↗
9 micro/small cap AI stocks are still in bubble mode advancing 14.8%, on average, last week. In comparison, the Global X Artificial Intelligence & Technology ETF was only up 0.5% and the iShares... 
Via Talk Markets
Topics Artificial Intelligence ETFs
News headline image
The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week ↗
If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to... 
Via Talk Markets
Topics Artificial Intelligence
News headline image
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November ↗
The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions. 
Via Talk Markets
Topics Artificial Intelligence
News headline image
November Recap: Top 9 Micro/Small Cap AI Stocks Up +53%, On Average ↗
The top 9 micro- and small-cap AI stocks advanced by 53%, on average, in November. 
Via Talk Markets
Topics Artificial Intelligence
News headline image
Hewlett Packard Enterprise Posts Upbeat Earnings, Joins Foot Locker, NetApp And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded higher, with the Nasdaq Composite gaining around 50 points on Wednesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) moved higher during Wednesday’s session following... 
Via Benzinga
Topics Stocks
News headline image
Recursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters. ↗
Scaling up means having more power to bring to bear on core activities. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth ↗
Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy. 
Via InvestorPlace
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The popular growth investor keeps adding to some of her favorite stocks. 
Via The Motley Fool
News headline image
Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off? ↗
Cathie Wood just gave the company a huge vote of confidence. 
Via The Motley Fool
News headline image
Unlocking AI investment opportunities in healthcare
AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities. 
Via MarketBeat
Topics Artificial Intelligence ETFs
News headline image
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock ↗
 
Via Benzinga
News headline image
AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence ↗
We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare. 
Via InvestorPlace
Topics Artificial Intelligence
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story